Skip to main content
. 2016 May 10;5(3):210–220. doi: 10.1159/000367767

Table 5.

Biomarkers and the clinical use in HCC after radiotherapy

Sample type No. of patients Assay Biomarkers proposed Comments References
Serum 42 Enzyme-linked immunoassay IL-6, SDF-1 Baseline IL-6, SDF-1 predicted PFS. Decreased SDF-1 at 1-month after RT completion predicted OS. [48]
Blood 22 EpCAM mRNA + CTC by qRT-PCR platform CTC Decrease in CTC levels after treatment that reflected tumor response. [49]

SDF-1=stem cell-derived factor-1; PFS=progression-free survival.